Physician

M. Ahsan Ullah, M.D.

According to 2025 Medicare claims, M. Ullah, M.D. (NPI: 1275538480) practices nephrology in the Springfield, OH market, with the plurality of this provider's patient population coming from Clark, OH. This provider's primary affiliated billing organization is ADVANCED NEPHROLOGY & HYPERTENSION (NPI: 1780069567; TIN: 320465385) and primary practice location at 45504-2687. Ullah is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Ullah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 425 traditional Medicare patients, billed 2,206 HCPCS/CPT codes, and received $167,743 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 6,504 prescription claims across 697 beneficiaries totaling $2,033,699 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 11 claims. Open Payments data shows 7 records totaling $232. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $355,995 to $2,033,699. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,507 and ending at $6,653.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	459	2,110	$176,253
2016	539	2,913	$257,050
2017	531	2,772	$249,636
2018	499	2,758	$257,642
2019	485	2,479	$236,813
2020	476	2,110	$193,463
2021	479	2,340	$243,501
2022	440	2,616	$258,187
2023	417	2,002	$200,888
2024	425	2,206	$167,743

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	437	5,483	$355,995
2016	463	5,967	$383,087
2017	468	5,893	$447,796
2018	505	5,858	$425,820
2019	500	5,155	$403,639
2020	491	5,108	$491,056
2021	521	5,047	$610,170
2022	545	5,174	$648,844
2023	594	5,759	$1,030,287
2024	697	6,504	$2,033,699

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$212
2016	N/R	49	$2,770
2017	N/R	17	$235
2018	N/R	21	$254
2019	N/R	22	$318
2020	N/R	16	$231
2021	N/R	N/R	N/R
2022	N/R	12	$1,430
2023	N/R	60	$1,490
2024	N/R	11	$5,949

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	40	40	$118
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	123	156	$96
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	139	732	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	271	553	$69
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	256	499	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	392	20,907	$383,731
Cortrophin	Corticotropin	11	187	$380,256
Jardiance	Empagliflozin	172	9,977	$192,364
Ozempic	Semaglutide	137	5,684	$144,072
Tolvaptan	Tolvaptan	11	390	$96,184

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	11	$5,949

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$232	Outset Medical Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for M. Ahsan Ullah, M.D.?

Tedicare shows public-source Medicare data for M. Ahsan Ullah, M.D. (NPI 1275538480), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does M. Ahsan Ullah, M.D. have ACO affiliation data?

M. Ahsan Ullah, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to M. Ahsan Ullah, M.D.?

M. Ahsan Ullah, M.D. is linked to ADVANCED NEPHROLOGY & HYPERTENSION (billing NPI 1780069567) in the available physician profile data.

Does M. Ahsan Ullah, M.D. have Open Payments data?

M. Ahsan Ullah, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.